Ester Garne

Ester Garne

Auto-generated profile, based on publicly available information

Ester Garne

Hospital Lillebaelt, Kolding, Denmark

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2001 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
EGE Garne
E Garne
CSC Stoll
C Stoll
MCM Clementi
M Clementi
EGEuroscan Group
Euroscan Group
Objectives: To evaluate prenatal diagnosis of congenital heart diseases by ultrasound investigation in well‐defined European populations.Design: Data from 20 registries of congenital malformations in 12 European countries were included. The prenatal ultrasound screening programs in the countries ranged from no routine screening to three ultrasound investigations per patient routinely performed.Results: There were 2454 cases with congenital heart disease with an overall prenatal detection rate of 25%. Termination of pregnancy was performed in 293 cases (12%). There was considerable variation in prenatal detection rate between regions, with the lowest detection rates being in countries without ultrasound screening (11%) and in Eastern European countries (Croatia, Lithuania and Ukraine; 8%). In Western European countries with ultrasound screening, detection rate ranged from 19–48%. There was a significant difference in prenatal detection rate and proportion of induced abortions between isolated congenital heart disease and congenital heart disease associated with chromosome anomalies, multiple malformations and syndromes (P < 0.0001). There were 1694 cases with isolated congenital heart disease of which 16% were diagnosed prenatally. Malformations affecting the size of the ventricles were detected prenatally in half of the cases.Conclusions: Prenatal detection rate of congenital heart disease varies significantly between countries even with the same screening recommendations. The presence of associated malformations significantly increases the prenatal detection rate. Copyright © 2001 International Society of Ultrasound in Obstetrics and Gynecology

23 December 2004 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
EGE. Garne
E. Garne
M:Maria :oane
Maria :oane
HDH. Dolk
H. Dolk
CVC. De Vigan
C. De Vigan
GSG. Scarano
G. Scarano
IBI. Barisic
I. Barisic
Objectives: To assess at a population‐based level the frequency with which severe structural congenital malformations are detected prenatally in Europe and the gestational age at detection, and to describe regional variation in these indicators.Methods: In the period 1995–1999, data were obtained from 17 European population‐based registries of congenital malformations (EUROCAT). Included were all live births, fetal deaths and terminations of pregnancy diagnosed with one or more of the following malformations: anencephalus, encephalocele, spina bifida, hydrocephalus, transposition of great arteries, hypoplastic left heart, limb reduction defect, bilateral renal agenesis, diaphragmatic hernia, omphalocele and gastroschisis.Results: The 17 registries reported 4366 cases diagnosed with the 11 severe structural malformations and of these 2300 were live births (53%), 181 were fetal deaths (4%) and 1863 were terminations of pregnancy (43%); in 22 cases pregnancy outcome was unknown. The overall prenatal detection rate was 64% (range, 25–88% across regions). The proportion of terminations of pregnancy varied between regions from 15% to 59% of all cases. Gestational age at discovery for prenatally diagnosed cases was less than 24 weeks for 68% (range, 36–88%) of cases. There was a significant relationship between high prenatal detection rate and early diagnosis (P < 0.0001). For individual malformations, the prenatal detection rate was highest for anencephalus (469/498, 94%) and lowest for transposition of the great arteries (89/324, 27%). Termination of pregnancy was performed in more than half of the prenatally diagnosed cases, except for those with transposition of the great arteries, diaphragmatic hernia and gastroschisis, in which 30–40% of the pregnancies with a prenatal diagnosis were terminated.Conclusion: European countries currently vary widely in the provision and uptake of prenatal screening and its quality, as well as the ‘culture’ in terms of decision to continue the pregnancy. This inevitably contributes to variation between countries in perinatal and infant mortality and in childhood prevalence and cost to health services of congenital anomalies. Copyright © 2004 ISUOG. Published by John Wiley & Sons, Ltd.

1 April 2002 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
EGE. Garne
E. Garne
MHM. Haeusler
M. Haeusler
IBI. Barisic
I. Barisic
RGR. Gjergja
R. Gjergja
CSC. Stoll
C. Stoll
MCM. Clementi
M. Clementi
Objective: To evaluate prenatal diagnosis of congenital diaphragmatic hernia by ultrasound in well‐defined European populations.Design: Data from 20 registries of congenital malformations in 12 European countries were included. The prenatal ultrasound screening programs in the countries ranged from no routine screening to three ultrasound investigations per patient being routinely performed.Results: There were 187 cases with congenital diaphragmatic hernia, with an overall prenatal detection rate of 59% (110/187). There was considerable variation in prenatal detection rate between regions. There was a significant difference in the detection rate of isolated congenital diaphragmatic hernia (59/116, 51%) compared with congenital diaphragmatic hernia associated with multiple malformations, karyotype anomalies or syndromes (51/71, 72%) (P = 0.01). Termination of pregnancy was performed in 39 cases (21%) of which 14 cases were isolated congenital diaphragmatic hernia. Mean gestational age at discovery was 24.2 weeks (range, 11–38 weeks).Conclusions: The overall prenatal detection rate of congenital diaphragmatic hernia is high (59%) but varies significantly between European regions. The gestational age at discovery was greater than 24 weeks in half of the prenatally diagnosed cases. Copyright © 2002 ISUOG

4 March 2011 in Birth Defects Research Part A: Clinical and Molecular Teratology
Verified
Journal Article
Open access
PDF file
RGRuth Greenlees
Ruth Greenlees
ANAmanda Neville
Amanda Neville
MAMarie–Claude Addor
Marie–Claude Addor
EAEmmanuelle Amar
Emmanuelle Amar
LALarraitz Arriola
Larraitz Arriola
WWWladimir Wertelecki
Wladimir Wertelecki
BACKGROUND: EUROCAT is a network of population‐based congenital anomaly registries providing standardized epidemiologic information on congenital anomalies in Europe. There are three types of EUROCAT membership: full, associate, or affiliate. Full member registries send individual records of all congenital anomalies covered by their region. Associate members transmit aggregate case counts for each EUROCAT anomaly subgroup by year and by type of birth. This article describes the organization and activities of each of the current 29 full member and 6 associate member registries of EUROCAT.METHODS: Each registry description provides information on the history and funding of the registry, population coverage including any changes in coverage over time, sources for ascertaining cases of congenital anomalies, and upper age limit for registering cases of congenital anomalies. It also details the legal requirements relating to termination of pregnancy for fetal anomalies, the definition of stillbirths and fetal deaths, and the prenatal screening policy within the registry. Information on availability of exposure information and denominators is provided. The registry description describes how each registry conforms to the laws and guidelines regarding ethics, consent, and confidentiality issues within their own jurisdiction. Finally, information on electronic and web‐based data capture, recent registry activities, and publications relating to congenital anomalies, along with the contact details of the registry leader, are provided.CONCLUSIONS: The registry description gives a detailed account of the organizational and operational aspects of each registry and is an invaluable resource that aids interpretation and evaluation of registry prevalence data. Birth Defects Research (Part A) , 2011.

1 March 2010 in European Journal of Paediatric Neurology
Verified
Journal Article
Closed access
EGEster Garne
Ester Garne
M:Maria :oane
Maria :oane
MAMarie-Claude Addor
Marie-Claude Addor
PBPatricia A. Boyd
Patricia A. Boyd
IBIngeborg Barisic
Ingeborg Barisic
HDHelen Dolk
Helen Dolk

8 April 2010 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Closed access
PDF file
EGE Garne
E Garne
BKB Khoshnood
B Khoshnood
M:Maria :oane
Maria :oane
PBPa Boyd
Pa Boyd
HDH Dolk
H Dolk
TGThe EUROCAT Working Group
The EUROCAT Working Group